Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

387
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
387
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

659
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
659
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

344
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

810
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
810
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacy Student Performance in a Capstone Course Utilizing the Pharmacists' Patient Care Process.

American journal of pharmaceutical education·2019
Same author

Using debates as the primary pedagogy to teach critical care in a PharmD curriculum elective course.

Currents in pharmacy teaching & learning·2019
Same author

Evaluation of the use of script concordance test in a multicampus psychiatric pharmacy elective course.

The mental health clinician·2019
Same author

Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA.

Drugs in R&D·2019
Same author

Rates of new antipsychotic prescriptions and continuation at discharge from a medical unit in a community teaching hospital serving rural counties.

The mental health clinician·2019
Same author

Evaluating the Use of Phenobarbital for the Management of Alcohol Withdrawal Syndrome in Psychiatric Inpatients.

Journal of pharmacy practice·2019

Related Experiment Video

Updated: Mar 22, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K

Medication adherence in patients with schizophrenia.

Stephanie V Phan1

  • 1University of Georgia College of Pharmacy, Albany, GA, USA sphan@uga.edu.

International Journal of Psychiatry in Medicine
|April 16, 2016
PubMed
Summary

Improving medication adherence in schizophrenia requires multifactorial strategies. Combining psychoeducation with behavioral interventions and involving patient support systems enhances treatment adherence for schizophrenia patients.

Keywords:
antipsychoticsmedication compliancenonadherenceschizophrenia

More Related Videos

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K

Related Experiment Videos

Last Updated: Mar 22, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

19.4K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.8K
Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.6K

Area of Science:

  • Psychiatry and Mental Health
  • Pharmacology
  • Clinical Psychology

Background:

  • Medication nonadherence is prevalent in schizophrenia, stemming from diverse factors like insight deficits, substance use, and treatment challenges.
  • Nonadherence significantly elevates risks of symptom relapse, hospitalization, functional decline, and mortality in schizophrenia patients.
  • Current psychoeducational interventions alone are insufficient, necessitating integrated approaches for effective schizophrenia treatment adherence.

Purpose of the Study:

  • To identify key factors contributing to medication nonadherence in schizophrenia.
  • To evaluate the efficacy of various interventions aimed at improving medication adherence in this population.
  • To emphasize the need for personalized, multifactorial strategies in managing schizophrenia treatment.

Main Methods:

  • Review of literature on factors influencing medication adherence in schizophrenia.
  • Analysis of the effectiveness of psychoeducational and behavioral interventions.
  • Examination of the role of patient support systems and pharmacotherapeutic optimization.
  • Assessment of strategies including patient involvement, therapeutic alliance, reminder systems, and substance use disorder management.

Main Results:

  • Multifactorial strategies, combining psychoeducation with behavioral interventions and support system involvement, show promise in improving adherence.
  • Optimizing pharmacotherapeutic regimens, patient engagement, therapeutic alliances, reminder systems, and addressing substance use are crucial.
  • No single technique is universally effective; continuous assessment and tailored, repeated interventions are necessary.

Conclusions:

  • Effective management of medication nonadherence in schizophrenia necessitates a comprehensive, individualized approach.
  • Integrating psychoeducational and behavioral strategies, alongside support systems and optimized pharmacotherapy, is key.
  • Ongoing assessment and adaptable, multifaceted interventions are vital for sustained treatment adherence throughout the illness course.